Industries · B2B healthcare · MedTech

A medtech marketing agency for clinical AI and SaMD companies

Marketing for SaMD, imaging AI and clinical decision support, where one verb can change your regulatory regime and every claim gets checked.

Senior team, no juniors on your account, 30-day cancellation notice. Your first call is with a co-founder.

10,000+
ABM engagements and 60+ sales interactions with deeply technical scientific accounts. Cradle case study.
Clients in healthcare and clinical AI

Results with clinical and scientific buyers

27
engaged hospital leads from a first ABM program (Coforix, hospital AI)
165
high-intent hospital contacts (Coforix)
10,000+
ABM engagements with scientific enterprise accounts (Cradle)
60+
sales interactions with target accounts (Cradle)
The job

Why medtech marketing needs a specialist

Your product sits near a clinical decision, which means your marketing sits near a regulator.

One verb decides your regime

FDA's January 2026 clinical decision support guidance draws the device line partly by wording, so “predicts” versus “flags for review” is a legal decision, and marketing owns the wording.

Two examinations, one sale

The CMIO and the CIO ask different questions, and neither uses the product. 92% of health systems now review third-party AI before deployment; under half can validate it in-house.

Buyers audit accuracy claims

The field taught them to: 44% of 224 funded digital health companies scored zero on published clinical evidence (JMIR, 2022). An unsourced accuracy number now reads as a warning sign.

Adoption is a second sale

In Kaiser Permanente's ambient AI rollout, 28% of 3,442 physicians passed 100 encounters in the first ten weeks. Sustained clinical use gets built after the contract, with the users.

Problems we solve

Problems we solve for medtech companies

First-call sentences from founders selling clinical software into hospitals. If two are yours, keep reading.

“Legal reviews every LinkedIn post, because 'predicts' and 'flags' are two different filings.”
What we hear
A claim library your legal team approves once, so campaigns stop renegotiating the same sentence.
What we do
“We have four hospital logos and three of them are pilots. The board counts contracts.”
What we hear
Pilot-to-production marketing: evidence packages, budget-holder readouts and reference-customer programs that convert pilots.
What we do
“The governance committee asked for subgroup performance by site. We had one retrospective study.”
What we hear
‍Publication-led content with your clinical team: validation write-ups structured so a committee can score them.‍
What we do
“Our champion is a radiologist with no budget. The buyer has never seen the product.”
What we hear
Committee mapping per account, with role-specific material your champion can forward to the CIO and finance.
What we do
“Pipeline is still the founders' hospital network, and we're raising next year.”
What we hear
ABM into named hospitals, reported by account and stage, so the board sees movement before revenue.
What we do
“We need marketing that doesn't make legal nervous.”
What we hear
Senior marketers who read your indications for use before writing a word, with substantiation attached to every claim.
What we do

Approach

Medtech digital marketing that survives regulatory review

Positioning, evidence content, account-based demand and safe measurement, run as one function by a senior team.

A claim library your lawyer approves once

We build the claim library from your regulatory file, attach substantiation to every sentence, and route drafts to your legal owner at outline stage. Review rounds shrink, campaigns ship inside the congress calendar, and nobody renegotiates the same sentence twice.

ABM into named hospitals

Europe's hospital market is countable and the US health-system list is finite, so demand generation is account-based by default: named accounts, role-specific messaging for CMIO and CIO, LinkedIn programs reported against the list rather than against clicks.

Congress and association strategy

Specialty associations and congresses reach the clinicians who stay off LinkedIn deliberately. We plan the year around your two or three decisive meetings, with podium support, side events, and follow-up that turns badge scans into evaluations.

Publication-led content

Co-authorship, case documentation and validation write-ups beat free pilots. We produce evidence content with your clinical team, structured so a governance committee can score it and an AI search engine can cite it.

Measurement without compliance risk

Tracking pixels on health pages have produced over $100 million in settlements since 2023. We audit tags and consent before the first campaign, keep patient data out of marketing entirely, and build attribution on account signals instead.

The rule we work by

Modest and substantiated beats impressive and retracted.

Results

Results for clinical software clients

Here's what two of our clients have seen. One sells AI to hospital teams and the other sells to research scientists.

Hospital AI
27 engaged hospital leads from 165 target contacts in six to seven months, as Coforix's first marketing function: generative AI for hospital administration, sold to the specific hospital team using each tool.
27
engaged hospital leads
165
target contacts
TechBio
10,000+ ABM engagements and 60+ sales interactions for Cradle, a deeply technical scientific product where every claim had to hold up in front of PhDs. The same discipline applies to clinicians.
10,000+
ABM engagements
60+
sales interactions

What Do they say?

We like to let our customers do the talking.

Your journey

Your first 90 days,
week by week

We don’t like to work from templates. Your Head of Growth builds the strategy around your product, your buyers and how hospitals evaluate clinical software. The cards below show one example for a healthtech company.

Kick off
●
Day 0

We meet your founders, commercial lead and clinical or regulatory lead, get access to the website, CRM and analytics, and agree what counts as a qualified request from a hospital.

Onboarding
KPI alignment
Ysabel CamusBerk Kalyoncu
Full audit
●
Weeks 1-2

We audit the website, search and AI-search visibility, paid accounts and tracking. With your sales team, we go through recent won and lost deals and check each product claim against your intended use and your clinical evidence.

Website and search
Claims check
Won and lost deals
Michaela RiesBerk KalyoncuYsabel Camus
Strategy & workshops
●
Weeks 3-4

Working sessions with your commercial, product and clinical leads. You leave with a plan written for your company: which segments come first, who decides in each hospital and which channels we use to reach them.

Segment priorities
Buyer map
Channel plan
Ysabel CamusMichaela RiesBerk Kalyoncu
Quick wins
●
Weeks 4-5

We fix tracking and the demo request flow, cut ad spend that reaches the wrong audience, and add the missing evidence, regulatory status and integration details to the product pages that already get traffic.

Request flow
Ad fixes
Product pages
Berk KalyoncuAlexandru Cojuhari
Product pages go live
●
Week 6+

Rebuilt product and use-case pages go onto the website, each with the clinical evidence, regulatory status and integration details a clinician or hospital IT lead will want to check.

Clinical evidence
Use-case pages
Comparison pages
Michaela RiesDaniela GutuAlexandru Cojuhari
Clinical content
●
Week 6+

We interview your clinical and product experts and publish under their names: evidence summaries, workflow guides and explainers, written at the level of detail a clinician expects.

Expert bylines
Evidence summaries
Search and AI search
Michaela RiesYsabel Camus
Named-account campaigns
●
Week 6+

Account-based campaigns on LinkedIn and paid search for an agreed list of target hospitals and health systems, with separate messages for the clinician, the department lead and procurement.

Target account list
LinkedIn
Paid search
Berk KalyoncuYsabel Camus
Conference plan
●
Week 6+

Ahead of the congresses that matter in your specialty, we book meetings with target accounts, prepare the follow-up and make sure booth conversations end up in the CRM.

Pre-booked meetings
Follow-up
CRM
Ysabel CamusDaniela Gutu
First pipeline report
●
Month 3

One report for your leadership team shows which target accounts engaged, how many demo, pilot and evaluation requests came in, and what we recommend for the next quarter. Pilots and full hospital contracts are reported separately.

Account engagement
Requests by segment
Next-quarter plan
Ysabel CamusBerk Kalyoncu
?
After day 90

Your Head of Growth goes through the results with you and adjusts the plan. Work that led to conversations with buyers gets more budget, and the rest is paused.

Review with you
Plan adjusted

Which healthcare market are you actually in?

Medtech borders two other markets, and the playbooks differ enough to keep separate pages.

You are here

MedTech and clinical software

Buyer: CMIO, CIO, clinicians and the AI governance committee between them. Proof bar: published validation. Scope: SaMD, imaging AI, decision support, monitoring.

Hardware and equipment

Medical devices

Physical devices and diagnostics hardware sold through procurement and value analysis committees. Proof bar: clinical data plus a per-procedure economic case.

Admin and infrastructure

Health tech

Hospital software without clinical claims: interoperability, admin AI, scheduling, revenue cycle. Buyer: CIO and operations. Proof bar: returned staff capacity.

Who you'll work with

No pitch team and no handoff to juniors: the Head of Growth who scopes your plan is on every call after it, with EU and US regimes covered by one team.

Team
Ysabel Camus
Head of Growth
James Eisner
James Eisner
Head of Growth
Michaela Ries
SEO / GEO Lead
Berk Kalyoncu
Berk Kalyoncu
Performance Specialist
Daniela Gutu
Daniela Gutu
Graphic Designer
Alexandru Cojuhari
Alexandru Cojuhari
Front End & Web Developer
André Antunes
André Antunes
RevOps & AI Lead
Daniel Bilici
Daniel Bilici
Sr. Growth Marketing Manager
Read our report · The State of Marketing in Health Tech

Who buys clinical software, which channels reach them, and why hype fails.

Marketing for the health tech industry in 2026 report cover

Practitioner interviews on hospital committees, clinician channels, the evidence bar for AI products and the compliance traps in health marketing. No form.

44%
of funded digital health companies: zero published clinical evidence
12
sections of desk-researched findings
6
practitioner interviews
Read the report
No form. If your clinical evidence is thin, section two will sting, usefully.
FAQ

Picking a medtech marketing agency: questions we get asked

Where we work

Amsterdam and New York, one team across GDPR and HIPAA markets, FDA and MDR regimes included.

What is medtech marketing?
What's the difference between medtech and medical device
marketing?
How do you market AI and SaMD without making regulated claims?
Do you understand FDA, CE/MDR and HIPAA?
How do you reach CMIOs versus practicing clinicians?
What evidence do we need before we start marketing?
How long does medtech marketing take to produce pipeline?
Do you work with physical devices and equipment?

Your first call is with a co-founder

The call is 30 minutes with the founder who has the most experience in your industry.

Book a 30-minute call